Ugh. Close to home here.
CDC report: Nebraskan among 6 with potential Johnson & Johnson vaccine clotting complication
OMAHA, Neb. (WOWT) - One of the six cases being examined in relation to the blood clot reports that halted the distribution of Johnson & Johnson COVID-19 vaccinations Tuesday is a Nebraska woman, according to a CDC report.
The Centers for Disease Control and Prevention and the Food and Drug Administration said Tuesday they were
investigating unusual clots that occurred 6 to 13 days after vaccination. The clots occurred in veins that drain blood from the brain and occurred together with low platelets. All six cases were in women between the ages of 18 and 48; there was one death and all remained under investigation.
According to a CDC report from April 2, the Nebraskan among the six is a 48-year-old woman who was vaccinated with
Johnson & Johnson Lot No. 1805020 on March 9 and is now “currently hospitalized with profound bleeding and clotting, suspect
dysfibrinogenemia, otherwise healthy without history of dysfibrinogenmeia.”
Dysfibrinogenemia is described by the National Institutes of Health as a clotting disorder caused by an abnormal form of a liver protein, called fibrinogen, that helps control bleeding.
The CDC report, via the Vaccine Adverse Event Reporting System known as VAERS, lists the woman’s condition as “serious” and “life-threatening.”